nach oben

European Journal of Epidemiology

Erschienen in:

01.08.2014 | Letter to the Editor

A pilot study of a genetic CJD risk factor (E200K) in the general Slovak population

verfasst von: Eva Mitrová, Dana Kosorinová, Martin Gajdoš, Katarína Šebeková, Ivana Tomečková

Erschienen in: European Journal of Epidemiology | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Excerpt

Creutzfeldt-Jakob disease (CJD) is a fatal, incurable human transmissible spongiform encephalopathy, or prion disease. Classical CJD has been recognised since the 1920s. CJD occurs in three forms : sporadic, of unknown origin, genetic, related to disease specific point mutations, insertions or deletions of the prion protein gene (PRNP) and iatrogenic (iCJD), caused by accidental transmission of the disease in the course of medical or surgical treatment. A new variant of CJD, which is causally related to bovine spongiform encephalopathy (BSE) was first described by Will et al. in 1996. …

Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D. Possible person -to -person transmission of Creutzfeldt- Jakob disease. N Engl J Med. 1974;290:692–3.PubMed

Kovács GG, Puopulo M, Ladogana A, Pocchiari M, Budka H, van Duijn C, et al. Genetic prion disease: the EUROCJD Experience. Hum Genet. 2005;118:166–74.PubMedCrossRef

Mitrova E, Belay G. Creutzfeldt-Jakob disease with E200 K mutation in Slovakia : characterization and development. Acta Virol. 2002;46:31–9.PubMed

Goldfarb L, Mitrová E, Brown P, Toh BK, Gajdusek DC. Mutation in codon 200 of scrapie amyloid protein gene in two clusters of CJD in Slovakia. The Lancet. 1990;336:514–5.CrossRef

Mitrová E, Černák A. Slivarichová D, Koščová, Černák M. Experience with preventive genetic testing of corneal donors. Cornea. 2011;30(7):987–90.PubMedCrossRef

Hill AF, Collinge J. Subclinical infection in humans and animals. Br Med Bull. 2003;66:161–70.PubMedCrossRef

Mitrová E. Some new aspects of CJD epidemiology in Slovakia. Eur J Epid. 1991;7:439–49.CrossRef

Collinge J, Palmer MS, Dryden AJ. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet. 1991;337:1441–2.PubMedCrossRef

Mitrová E, Mayer V, Jovankovičová V, Slivarichová D, Wsólová L. CJD risk and PRNP polymorphism : necessity to revalue current data. Europ J Neurol. 2005;12:1–4.CrossRef

10.

Kovács GG, László L, Bakos J, Mitrová E, Majtényi K. Increased incidence of genetic human prion disease in Hungary. Neurology. 2005;65:1–7.CrossRef

Titel: A pilot study of a genetic CJD risk factor (E200K) in the general Slovak population
verfasst von: Eva Mitrová
Dana Kosorinová
Martin Gajdoš
Katarína Šebeková
Ivana Tomečková
Publikationsdatum: 01.08.2014
Verlag: Springer Netherlands
Erschienen in: European Journal of Epidemiology / Ausgabe 8/2014
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI: https://doi.org/10.1007/s10654-014-9937-9

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2014

Hours lying down per day and mortality from all-causes and cardiovascular disease: the HUNT Study, Norway

Cord blood 25(OH)D levels and the subsequent risk of lower respiratory tract infections in early childhood: the Ulm birth cohort

National registers and their use for medical research

Night work and breast cancer risk in a general population prospective cohort study in The Netherlands

Assessment of risk factors for developing incident aortic stenosis: the Tromsø Study

When the entire population is the sample: strengths and limitations in register-based epidemiology